Global Follicle-stimulating Hormone (FSH) Market Research Report 2020

This report focuses on Follicle-stimulating Hormone (FSH) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Follicle-stimulating Hormone (FSH) market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

    Merck Serono

    MSD

    IBSA

    Ferring

    Livzon

    Techwell

    GenSci

    ...

    North America

    Europe

    China

    Japan

    Recombinant FSH

    Urinary FSH

    Infertility Treatment

    Assisted Reproductive Technology

Table of Contents

1.1 Product Overview and Scope of Follicle-stimulating Hormone (FSH)

1.2 Follicle-stimulating Hormone (FSH) Segment by Type

1.2.1 Global Follicle-stimulating Hormone (FSH) Sales Growth Rate Comparison by Type (2021-2026)

1.2.2 Recombinant FSH

1.2.3 Urinary FSH

1.3 Follicle-stimulating Hormone (FSH) Segment by Application

1.3.1 Follicle-stimulating Hormone (FSH) Sales Comparison by Application: 2020 VS 2026

1.3.2 Infertility Treatment

1.3.3 Assisted Reproductive Technology

1.4 Global Follicle-stimulating Hormone (FSH) Market Size Estimates and Forecasts

1.4.1 Global Follicle-stimulating Hormone (FSH) Revenue 2015-2026

1.4.2 Global Follicle-stimulating Hormone (FSH) Sales 2015-2026

1.4.3 Follicle-stimulating Hormone (FSH) Market Size by Region: 2020 Versus 2026

2.1 Global Follicle-stimulating Hormone (FSH) Sales Market Share by Manufacturers (2015-2020)

2.2 Global Follicle-stimulating Hormone (FSH) Revenue Share by Manufacturers (2015-2020)

2.3 Global Follicle-stimulating Hormone (FSH) Average Price by Manufacturers (2015-2020)

2.4 Manufacturers Follicle-stimulating Hormone (FSH) Manufacturing Sites, Area Served, Product Type

2.5 Follicle-stimulating Hormone (FSH) Market Competitive Situation and Trends

2.5.1 Follicle-stimulating Hormone (FSH) Market Concentration Rate

2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue

2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

2.7 Primary Interviews with Key Follicle-stimulating Hormone (FSH) Players (Opinion Leaders)

3.1 Global Follicle-stimulating Hormone (FSH) Retrospective Market Scenario in Sales by Region: 2015-2020

3.2 Global Follicle-stimulating Hormone (FSH) Retrospective Market Scenario in Revenue by Region: 2015-2020

3.3 North America Follicle-stimulating Hormone (FSH) Market Facts & Figures by Country

3.3.1 North America Follicle-stimulating Hormone (FSH) Sales by Country

3.3.2 North America Follicle-stimulating Hormone (FSH) Sales by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Follicle-stimulating Hormone (FSH) Market Facts & Figures by Country

3.4.1 Europe Follicle-stimulating Hormone (FSH) Sales by Country

3.4.2 Europe Follicle-stimulating Hormone (FSH) Sales by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Follicle-stimulating Hormone (FSH) Market Facts & Figures by Region

3.5.1 Asia Pacific Follicle-stimulating Hormone (FSH) Sales by Region

3.5.2 Asia Pacific Follicle-stimulating Hormone (FSH) Sales by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Follicle-stimulating Hormone (FSH) Market Facts & Figures by Country

3.6.1 Latin America Follicle-stimulating Hormone (FSH) Sales by Country

3.6.2 Latin America Follicle-stimulating Hormone (FSH) Sales by Country

3.6.3 Mexico

3.6.3 Brazil

3.6.3 Argentina

3.7 Middle East and Africa Follicle-stimulating Hormone (FSH) Market Facts & Figures by Country

3.7.1 Middle East and Africa Follicle-stimulating Hormone (FSH) Sales by Country

3.7.2 Middle East and Africa Follicle-stimulating Hormone (FSH) Sales by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 U.A.E

4.1 Global Follicle-stimulating Hormone (FSH) Sales Market Share by Type (2015-2020)

4.2 Global Follicle-stimulating Hormone (FSH) Revenue Market Share by Type (2015-2020)

4.3 Global Follicle-stimulating Hormone (FSH) Price Market Share by Type (2015-2020)

4.4 Global Follicle-stimulating Hormone (FSH) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5.1 Global Follicle-stimulating Hormone (FSH) Sales Market Share by Application (2015-2020)

5.2 Global Follicle-stimulating Hormone (FSH) Revenue Market Share by Application (2015-2020)

5.3 Global Follicle-stimulating Hormone (FSH) Price by Application (2015-2020)

6.1 Merck Serono

6.1.1 Corporation Information

6.1.2 Merck Serono Description, Business Overview and Total Revenue

6.1.3 Merck Serono Follicle-stimulating Hormone (FSH) Sales, Revenue and Gross Margin (2015-2020)

6.1.4 Merck Serono Products Offered

6.1.5 Merck Serono Recent Development

6.2 MSD

6.2.1 MSD Follicle-stimulating Hormone (FSH) Production Sites and Area Served

6.2.2 MSD Description, Business Overview and Total Revenue

6.2.3 MSD Follicle-stimulating Hormone (FSH) Sales, Revenue and Gross Margin (2015-2020)

6.2.4 MSD Products Offered

6.2.5 MSD Recent Development

6.3 IBSA

6.3.1 IBSA Follicle-stimulating Hormone (FSH) Production Sites and Area Served

6.3.2 IBSA Description, Business Overview and Total Revenue

6.3.3 IBSA Follicle-stimulating Hormone (FSH) Sales, Revenue and Gross Margin (2015-2020)

6.3.4 IBSA Products Offered

6.3.5 IBSA Recent Development

6.4 Ferring

6.4.1 Ferring Follicle-stimulating Hormone (FSH) Production Sites and Area Served

6.4.2 Ferring Description, Business Overview and Total Revenue

6.4.3 Ferring Follicle-stimulating Hormone (FSH) Sales, Revenue and Gross Margin (2015-2020)

6.4.4 Ferring Products Offered

6.4.5 Ferring Recent Development

6.5 Livzon

6.5.1 Livzon Follicle-stimulating Hormone (FSH) Production Sites and Area Served

6.5.2 Livzon Description, Business Overview and Total Revenue

6.5.3 Livzon Follicle-stimulating Hormone (FSH) Sales, Revenue and Gross Margin (2015-2020)

6.5.4 Livzon Products Offered

6.5.5 Livzon Recent Development

6.6 Techwell

6.6.1 Techwell Follicle-stimulating Hormone (FSH) Production Sites and Area Served

6.6.2 Techwell Description, Business Overview and Total Revenue

6.6.3 Techwell Follicle-stimulating Hormone (FSH) Sales, Revenue and Gross Margin (2015-2020)

6.6.4 Techwell Products Offered

6.6.5 Techwell Recent Development

6.7 GenSci

6.6.1 GenSci Follicle-stimulating Hormone (FSH) Production Sites and Area Served

6.6.2 GenSci Description, Business Overview and Total Revenue

6.6.3 GenSci Follicle-stimulating Hormone (FSH) Sales, Revenue and Gross Margin (2015-2020)

6.4.4 GenSci Products Offered

6.7.5 GenSci Recent Development

7.1 Follicle-stimulating Hormone (FSH) Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Raw Materials Price Trend

7.1.3 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Follicle-stimulating Hormone (FSH)

7.4 Follicle-stimulating Hormone (FSH) Industrial Chain Analysis

8.1 Marketing Channel

8.2 Follicle-stimulating Hormone (FSH) Distributors List

8.3 Follicle-stimulating Hormone (FSH) Customers

9.1 Market Trends

9.2 Opportunities and Drivers

9.3 Challenges

9.4 Porter's Five Forces Analysis

10.1 Global Follicle-stimulating Hormone (FSH) Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Follicle-stimulating Hormone (FSH) by Type (2021-2026)

10.1.2 Global Forecasted Revenue of Follicle-stimulating Hormone (FSH) by Type (2021-2026)

10.2 Follicle-stimulating Hormone (FSH) Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Follicle-stimulating Hormone (FSH) by Application (2021-2026)

10.2.2 Global Forecasted Revenue of Follicle-stimulating Hormone (FSH) by Application (2021-2026)

10.3 Follicle-stimulating Hormone (FSH) Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Follicle-stimulating Hormone (FSH) by Region (2021-2026)

10.3.2 Global Forecasted Revenue of Follicle-stimulating Hormone (FSH) by Region (2021-2026)

10.4 North America Follicle-stimulating Hormone (FSH) Estimates and Projections (2021-2026)

10.5 Europe Follicle-stimulating Hormone (FSH) Estimates and Projections (2021-2026)

10.6 Asia Pacific Follicle-stimulating Hormone (FSH) Estimates and Projections (2021-2026)

10.7 Latin America Follicle-stimulating Hormone (FSH) Estimates and Projections (2021-2026)

10.8 Middle East and Africa Follicle-stimulating Hormone (FSH) Estimates and Projections (2021-2026)

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

List of Tables

    Table 1. Global Follicle-stimulating Hormone (FSH) Sales (K Doses) Growth Rate Comparison by Type (2015-2026)

    Table 2. Global Follicle-stimulating Hormone (FSH) Sales (K Doses) Comparison by Application: 2020 VS 2026

    Table 3. Global Follicle-stimulating Hormone (FSH) Market Size by Type (K Doses) (US$ Million) (2020 VS 2026)

    Table 4. Global Key Follicle-stimulating Hormone (FSH) Manufacturers Covered in This Study

    Table 5. Global Follicle-stimulating Hormone (FSH) Sales (K Doses) by Manufacturers (2015-2020)

    Table 6. Global Follicle-stimulating Hormone (FSH) Sales Share by Manufacturers (2015-2020)

    Table 7. Global Follicle-stimulating Hormone (FSH) Revenue (Million USD) by Manufacturers (2015-2020)

    Table 8. Global Follicle-stimulating Hormone (FSH) Revenue Share by Manufacturers (2015-2020)

    Table 9. Global Market Follicle-stimulating Hormone (FSH) Average Price (USD/Dose) of Key Manufacturers (2015-2020)

    Table 10. Manufacturers Follicle-stimulating Hormone (FSH) Sales Sites and Area Served

    Table 11. Manufacturers Follicle-stimulating Hormone (FSH) Product Types

    Table 12. Global Follicle-stimulating Hormone (FSH) Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 13. Global Follicle-stimulating Hormone (FSH) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Follicle-stimulating Hormone (FSH) as of 2019)

    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 15. Main Points Interviewed from Key Follicle-stimulating Hormone (FSH) Players

    Table 16. Global Follicle-stimulating Hormone (FSH) Sales (K Doses) by Region (2015-2020)

    Table 17. Global Follicle-stimulating Hormone (FSH) Sales Market Share by Region (2015-2020)

    Table 18. Global Follicle-stimulating Hormone (FSH) Revenue (Million US$) by Region (2015-2020)

    Table 19. Global Follicle-stimulating Hormone (FSH) Revenue Market Share by Region (2015-2020)

    Table 20. North America Follicle-stimulating Hormone (FSH) Sales by Country (2015-2020) (K Doses)

    Table 21. North America Follicle-stimulating Hormone (FSH) Sales Market Share by Country (2015-2020)

    Table 22. North America Follicle-stimulating Hormone (FSH) Revenue by Country (2015-2020) (US$ Million)

    Table 23. North America Follicle-stimulating Hormone (FSH) Revenue Market Share by Country (2015-2020)

    Table 24. Europe Follicle-stimulating Hormone (FSH) Sales by Country (2015-2020) (K Doses)

    Table 25. Europe Follicle-stimulating Hormone (FSH) Sales Market Share by Country (2015-2020)

    Table 26. Europe Follicle-stimulating Hormone (FSH) Revenue by Country (2015-2020) (US$ Million)

    Table 27. Europe Follicle-stimulating Hormone (FSH) Revenue Market Share by Country (2015-2020)

    Table 28. Asia Pacific Follicle-stimulating Hormone (FSH) Sales by Region (2015-2020) (K Doses)

    Table 29. Asia Pacific Follicle-stimulating Hormone (FSH) Sales Market Share by Region (2015-2020)

    Table 30. Asia Pacific Follicle-stimulating Hormone (FSH) Revenue by Region (2015-2020) (US$ Million)

    Table 31. Asia Pacific Follicle-stimulating Hormone (FSH) Revenue Market Share by Region (2015-2020)

    Table 32. Latin America Follicle-stimulating Hormone (FSH) Sales by Country (2015-2020) (K Doses)

    Table 33. Latin America Follicle-stimulating Hormone (FSH) Sales Market Share by Country (2015-2020)

    Table 34. Latin America Follicle-stimulating Hormone (FSH) Revenue by Country (2015-2020) (US$ Million)

    Table 35. Latin America Follicle-stimulating Hormone (FSH) Revenue Market Share by Country (2015-2020)

    Table 36. Middle East and Africa Follicle-stimulating Hormone (FSH) Sales by Country (2015-2020) (K Doses)

    Table 37. Middle East and Africa Follicle-stimulating Hormone (FSH) Sales Market Share by Country (2015-2020)

    Table 38. Middle East and Africa Follicle-stimulating Hormone (FSH) Revenue by Country (2015-2020) (US$ Million)

    Table 39. Middle East and Africa Follicle-stimulating Hormone (FSH) Revenue Market Share by Country (2015-2020)

    Table 40. Global Follicle-stimulating Hormone (FSH) Sales (K Doses) by Type (2015-2020)

    Table 41. Global Follicle-stimulating Hormone (FSH) Sales Share by Type (2015-2020)

    Table 42. Global Follicle-stimulating Hormone (FSH) Revenue (Million US$) by Type (2015-2020)

    Table 43. Global Follicle-stimulating Hormone (FSH) Revenue Share by Type (2015-2020)

    Table 44. Global Follicle-stimulating Hormone (FSH) Price (USD/Dose) by Type (2015-2020)

    Table 45. Global Follicle-stimulating Hormone (FSH) Sales (K Doses) by Application (2015-2020)

    Table 46. Global Follicle-stimulating Hormone (FSH) Sales Market Share by Application (2015-2020)

    Table 47. Global Follicle-stimulating Hormone (FSH) Sales Growth Rate by Application (2015-2020)

    Table 48. Merck Serono Follicle-stimulating Hormone (FSH) Corporation Information

    Table 49. Merck Serono Description and Business Overview

    Table 50. Merck Serono Follicle-stimulating Hormone (FSH) Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

    Table 51. Merck Serono Main Product

    Table 52. Merck Serono Recent Development

    Table 53. MSD Follicle-stimulating Hormone (FSH) Corporation Information

    Table 54. MSD Corporation Information

    Table 55. MSD Follicle-stimulating Hormone (FSH) Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

    Table 56. MSD Main Product

    Table 57. MSD Recent Development

    Table 58. IBSA Follicle-stimulating Hormone (FSH) Corporation Information

    Table 59. IBSA Corporation Information

    Table 60. IBSA Follicle-stimulating Hormone (FSH) Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

    Table 61. IBSA Main Product

    Table 62. IBSA Recent Development

    Table 63. Ferring Follicle-stimulating Hormone (FSH) Corporation Information

    Table 64. Ferring Corporation Information

    Table 65. Ferring Follicle-stimulating Hormone (FSH) Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

    Table 66. Ferring Main Product

    Table 67. Ferring Recent Development

    Table 68. Livzon Follicle-stimulating Hormone (FSH) Corporation Information

    Table 69. Livzon Corporation Information

    Table 70. Livzon Follicle-stimulating Hormone (FSH) Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

    Table 71. Livzon Main Product

    Table 72. Livzon Recent Development

    Table 73. Techwell Follicle-stimulating Hormone (FSH) Corporation Information

    Table 74. Techwell Corporation Information

    Table 75. Techwell Follicle-stimulating Hormone (FSH) Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

    Table 76. Techwell Main Product

    Table 77. Techwell Recent Development

    Table 78. GenSci Follicle-stimulating Hormone (FSH) Corporation Information

    Table 79. GenSci Corporation Information

    Table 80. GenSci Follicle-stimulating Hormone (FSH) Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)

    Table 81. GenSci Main Product

    Table 82. GenSci Recent Development

    Table 83. Sales Base and Market Concentration Rate of Raw Material

    Table 84. Key Suppliers of Raw Materials

    Table 85. Follicle-stimulating Hormone (FSH) Distributors List

    Table 86. Follicle-stimulating Hormone (FSH) Customers List

    Table 87. Market Key Trends

    Table 88. Key Opportunities and Drivers: Impact Analysis (2021-2026)

    Table 89. Key Challenges

    Table 90. Global Follicle-stimulating Hormone (FSH) Sales (K Doses) Forecast by Type (2021-2026)

    Table 91. Global Follicle-stimulating Hormone (FSH) Sales Market Share Forecast by Type (2021-2026)

    Table 92. Global Follicle-stimulating Hormone (FSH) Revenue (Million US$) Forecast by Type (2021-2026)

    Table 93. Global Follicle-stimulating Hormone (FSH) Revenue (Million US$) Market Share Forecast by Type (2021-2026)

    Table 94. Global Follicle-stimulating Hormone (FSH) Sales (K Doses) Forecast by Application (2021-2026)

    Table 95. Global Follicle-stimulating Hormone (FSH) Revenue (Million US$) Forecast by Application (2021-2026)

    Table 96. Global Follicle-stimulating Hormone (FSH) Sales (K Doses) Forecast by Region (2021-2026)

    Table 97. Global Follicle-stimulating Hormone (FSH) Sales Market Share Forecast by Region (2021-2026)

    Table 98. Global Follicle-stimulating Hormone (FSH) Revenue Forecast by Region (2021-2026) (US$ Million)

    Table 99. Global Follicle-stimulating Hormone (FSH) Revenue Market Share Forecast by Region (2021-2026)

    Table 100. Research Programs/Design for This Report

    Table 101. Key Data Information from Secondary Sources

    Table 102. Key Data Information from Primary Sources

List of Figures

    Figure 1. Picture of Follicle-stimulating Hormone (FSH)

    Figure 2. Global Follicle-stimulating Hormone (FSH) Sales Market Share by Type: 2020 VS 2026

    Figure 3. Recombinant FSH Product Picture

    Figure 4. Urinary FSH Product Picture

    Figure 5. Global Follicle-stimulating Hormone (FSH) Consumption Market Share by Application: 2020 VS 2026

    Figure 6. Infertility Treatment

    Figure 7. Assisted Reproductive Technology

    Figure 8. Global Follicle-stimulating Hormone (FSH) Market Size 2015-2026 (US$ Million)

    Figure 9. Global Follicle-stimulating Hormone (FSH) Sales Capacity (K Doses) (2015-2026)

    Figure 10. Global Follicle-stimulating Hormone (FSH) Market Size Market Share by Region: 2020 Versus 2026

    Figure 11. Follicle-stimulating Hormone (FSH) Sales Share by Manufacturers in 2020

    Figure 12. Global Follicle-stimulating Hormone (FSH) Revenue Share by Manufacturers in 2019

    Figure 13. The Global 5 and 10 Largest Players: Market Share by Follicle-stimulating Hormone (FSH) Revenue in 2019

    Figure 14. Follicle-stimulating Hormone (FSH) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

    Figure 15. Global Follicle-stimulating Hormone (FSH) Sales Market Share by Region (2015-2020)

    Figure 16. Global Follicle-stimulating Hormone (FSH) Sales Market Share by Region in 2019

    Figure 17. Global Follicle-stimulating Hormone (FSH) Revenue Market Share by Region (2015-2020)

    Figure 18. Global Follicle-stimulating Hormone (FSH) Revenue Market Share by Region in 2019

    Figure 19. North America Follicle-stimulating Hormone (FSH) Sales Market Share by Country in 2019

    Figure 20. North America Follicle-stimulating Hormone (FSH) Revenue Market Share by Country in 2019

    Figure 21. U.S. Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)

    Figure 22. U.S. Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 23. Canada Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)

    Figure 24. Canada Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 25. Europe Follicle-stimulating Hormone (FSH) Sales Market Share by Country in 2019

    Figure 26. Europe Follicle-stimulating Hormone (FSH) Revenue Market Share by Country in 2019

    Figure 27. Germany Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)

    Figure 28. Germany Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 29. France Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)

    Figure 30. France Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 31. U.K. Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)

    Figure 32. U.K. Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 33. Italy Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)

    Figure 34. Italy Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 35. Russia Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)

    Figure 36. Russia Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 37. Asia Pacific Follicle-stimulating Hormone (FSH) Sales Market Share by Region in 2019

    Figure 38. Asia Pacific Follicle-stimulating Hormone (FSH) Revenue Market Share by Region in 2019

    Figure 39. China Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)

    Figure 40. China Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 41. Japan Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)

    Figure 42. Japan Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 43. South Korea Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)

    Figure 44. South Korea Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 45. India Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)

    Figure 46. India Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 47. Australia Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)

    Figure 48. Australia Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 49. Taiwan Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)

    Figure 50. Taiwan Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 51. Indonesia Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)

    Figure 52. Indonesia Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 53. Thailand Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)

    Figure 54. Thailand Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 55. Malaysia Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)

    Figure 56. Malaysia Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 57. Philippines Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)

    Figure 58. Philippines Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 59. Vietnam Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)

    Figure 60. Vietnam Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 61. Latin America Follicle-stimulating Hormone (FSH) Sales Market Share by Country in 2019

    Figure 62. Latin America Follicle-stimulating Hormone (FSH) Revenue Market Share by Country in 2019

    Figure 63. Mexico Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)

    Figure 64. Mexico Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 65. Brazil Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)

    Figure 66. Brazil Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 67. Argentina Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)

    Figure 68. Argentina Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 69. Middle East and Africa Follicle-stimulating Hormone (FSH) Sales Market Share by Country in 2019

    Figure 70. Middle East and Africa Follicle-stimulating Hormone (FSH) Revenue Market Share by Country in 2019

    Figure 71. Turkey Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)

    Figure 72. Turkey Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 73. Saudi Arabia Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)

    Figure 74. Saudi Arabia Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 75. U.A.E Follicle-stimulating Hormone (FSH) Sales Growth Rate (2015-2020) (K Doses)

    Figure 76. U.A.E Follicle-stimulating Hormone (FSH) Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 77. Sales Market Share of Follicle-stimulating Hormone (FSH) by Type (2015-2020)

    Figure 78. Sales Market Share of Follicle-stimulating Hormone (FSH) by Type in 2019

    Figure 79. Revenue Share of Follicle-stimulating Hormone (FSH) by Type (2015-2020)

    Figure 80. Revenue Market Share of Follicle-stimulating Hormone (FSH) by Type in 2019

    Figure 81. Global Follicle-stimulating Hormone (FSH) Sales Growth by Type (2015-2020) (K Doses)

    Figure 82. Global Follicle-stimulating Hormone (FSH) Sales Market Share by Application (2015-2020)

    Figure 83. Global Follicle-stimulating Hormone (FSH) Sales Market Share by Application in 2019

    Figure 84. Global Revenue Share of Follicle-stimulating Hormone (FSH) by Application (2015-2020)

    Figure 85. Global Revenue Share of Follicle-stimulating Hormone (FSH) by Application in 2020

    Figure 86. Merck Serono Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 87. MSD Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 88. IBSA Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 89. Ferring Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 90. Livzon Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 91. Techwell Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 92. GenSci Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 93. Price Trend of Key Raw Materials

    Figure 94. Manufacturing Cost Structure of Follicle-stimulating Hormone (FSH)

    Figure 95. Manufacturing Process Analysis of Follicle-stimulating Hormone (FSH)

    Figure 96. Follicle-stimulating Hormone (FSH) Industrial Chain Analysis

    Figure 97. Channels of Distribution

    Figure 98. Distributors Profiles

    Figure 99. Porter's Five Forces Analysis

    Figure 100. North America Follicle-stimulating Hormone (FSH) Sales (K Doses) and Growth Rate Forecast (2021-2026)

    Figure 101. North America Follicle-stimulating Hormone (FSH) Revenue (Million US$) and Growth Rate Forecast (2021-2026)

    Figure 102. Europe Follicle-stimulating Hormone (FSH) Sales (K Doses) and Growth Rate Forecast (2021-2026)

    Figure 103. Europe Follicle-stimulating Hormone (FSH) Revenue (Million US$) and Growth Rate Forecast (2021-2026)

    Figure 104. Latin America Follicle-stimulating Hormone (FSH) Sales (K Doses) and Growth Rate Forecast (2021-2026)

    Figure 105. Latin America Follicle-stimulating Hormone (FSH) Revenue (Million US$) and Growth Rate Forecast (2021-2026)

    Figure 106. Middle East and Africa Follicle-stimulating Hormone (FSH) Sales (K Doses) and Growth Rate Forecast (2021-2026)

    Figure 107. Middle East and Africa Follicle-stimulating Hormone (FSH) Revenue (Million US$) and Growth Rate Forecast (2021-2026)

    Figure 108. Asia Pacific Follicle-stimulating Hormone (FSH) Sales (K Doses) and Growth Rate Forecast (2021-2026)

    Figure 109. Asia Pacific Follicle-stimulating Hormone (FSH) Revenue (Million US$) and Growth Rate Forecast (2021-2026)

    Figure 110. Bottom-up and Top-down Approaches for This Report

    Figure 111. Data Triangulation

    Figure 112. Key Executives Interviewed